XHSynbio Overview
- Year Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Series B
- Investors
-
5
XHSynbio General Information
Description
Developer of pharmaceutical enzymes and chiral chemicals intended for industrial biotechnology and pharmaceutical manufacturing in China. The company's range of products includes enzyme preparations, chiral drug intermediates, nutritional additives, fermentation-derived compounds, specialty reagents and active pharmaceutical ingredients, thereby enabling high-value production through advanced biotechnological processes.
Contact Information
Website
www.xhsynbio.comCorporate Office
- 2nd Floor, East Gate, Building 1
- Number 366, Jinpeng Street, Xihu District
- Hangzhou, Zhejiang 310030
- China
Corporate Office
- 2nd Floor, East Gate, Building 1
- Number 366, Jinpeng Street, Xihu District
- Hangzhou, Zhejiang 310030
- China
XHSynbio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B) | 15-Aug-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 05-Mar-2025 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 23-Aug-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 24-May-2024 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 10-Mar-2023 | Completed | Generating Revenue | |||
| 1. Later Stage VC | 06-Aug-2021 | Completed | Generating Revenue |
XHSynbio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Xi'an Royal-Power Asset Management | Venture Capital | Minority | ||
| Sinochem Capital | Corporate Venture Capital | Minority | ||
| Xihu VC | Government | Minority | ||
| Zhejiang Xianju Pharmaceutical Company | Corporation | Minority | ||
| Goldport Capital | Venture Capital | Minority |
XHSynbio FAQs
-
When was XHSynbio founded?
XHSynbio was founded in 2015.
-
Where is XHSynbio headquartered?
XHSynbio is headquartered in Hangzhou, China.
-
What industry is XHSynbio in?
XHSynbio’s primary industry is Specialty Chemicals.
-
Is XHSynbio a private or public company?
XHSynbio is a Private company.
-
What is XHSynbio’s current revenue?
The current revenue for XHSynbio is .
-
Who are XHSynbio’s investors?
Xi'an Royal-Power Asset Management, Sinochem Capital, Xihu VC, Zhejiang Xianju Pharmaceutical Company, and Goldport Capital have invested in XHSynbio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process